Synonyms:bromocriptine, Bromocryptine, 25614-03-3, Bromocriptin, Bromoergocryptine, Bromergocryptine, Bromoergocriptine, 2-Bromo-alpha-ergocryptine, 2-Bromo-alpha-ergokryptine, Bromocriptina, Bromocriptinum, 2-Bromo-alpha-ergokryptin, Bromocriptinum [INN-Latin], Bromocriptina [INN-Spanish], Ergocryptine, 2-bromo-, CB-154, Bagren, 2-Bromoergocryptine, 3A64E3G5ZO, Bromocriptine (mesylate), CHEBI:3181, Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-, DTXSID1022687, Ergoset, SANDOZ 15-754, Bromergon, (+)-Bromocriptine, CB 154, Bromokryptine, (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman, Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-, 2-Bromo-.alpha.-ergocryptine, (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide, CCRIS 3244, NSC169774, EINECS 247-128-5, Bromocriptine (USAN/INN), UNII-3A64E3G5ZO, SR-01000075356, Bromocriptine [USAN:INN:BAN], NCGC00024584-03, 08Y, 2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione, Bromocriptine+ (GTP-), Prestwick0_000121, Prestwick1_000121, Prestwick2_000121, Carboprost Methylate,(S), BROMOCRIPTINE [MI], Biomol-NT_000005, CHEMBL493, GTPL35, BROMOCRIPTINE [INN], BROMOCRIPTINE [USAN], Lopac0_000171, SCHEMBL25297, BROMOCRIPTINE [VANDF], (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione, BIDD:GT0464, SPBio_002101, BROMOCRIPTINE [WHO-DD], BPBio1_001131, DTXCID602687, BDBM81993, Tox21_110907, PDSP2_001500, AKOS015961273, CCG-204266, DB01200, SDCCGSBI-0050159.P003, (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman, dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo, NCGC00024584-04, NCGC00024584-05, NCGC00024584-07, NCGC00024584-09, (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman, (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide, AC-13601, NCI60_001365, 10b-hydroxy-5-isobutyl-2-isopropyl-3,6-, CAS-25614-03-3, C06856, D03165, hexahydroindolo[4,3-fg]quinoline-9-carboxamide, EN300-19768234, Q413581, J-016067, SR-01000075356-5, (6aR,9R)-5-bromo-N-((2R,5S,10aS,10bS)-, [2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-, BRD-K14496212-001-01-1, BRD-K14496212-066-04-8, SAN 15-754; Sandoz 15-754; -Bromocryptine; -Bromoergocryptine; -Ergolactin, (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide, (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide, N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide
Pubchem:PUBCHEM:31101
Id:5ffc6a18-95ac-54f3-aba2-3d7785f03e17
Description:nan